Rh flow cytometry: An updated methodology for D antigen density applied to weak D types 164 and 165
Transfusion · 2023
DOI: 10.1111/trf.17543 ↗At a glance
Journal article in Transfusion, 2023. Written by Chloe Jayne Hutchison and 4 co-authors. Institution: Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. Major MEDLINE topics: Erythrocytes, Rh-Hr Blood-Group System. Cited 1 times so far (Crossref); 92 references. The full text is freely available in PubMed Central. Funded by: Intramural NIH HHS, NIH Clinical Center.
Abstract (original language)
Background
An original methodology for determining the D antigen density on red cells was published in 2000 and has been applied in many publications since. This flow cytometry‐based assay remained largely unrevised utilizing monoclonal anti‐Ds that are not readily available anymore. We updated the methodology to quantify erythrocyte D antigen sites using microspheres and monoclonal anti‐Ds that are commercially available today.
Methods
The absolute D antigen density of a frozen standard CcDEe cell, drawn in 2003, a fresh blood donation from the same individual, drawn in 2022, and an internal control CcDEe cell, was quantified by flow cytometry using fluorescence‐labeled microspheres. The internal control CcDEe cell was used in conjunction with 9 commercial anti‐Ds to determine D antigen densities of 7 normal D, 4 partial D, and 11 weak D type samples, including 2 novel alleles.
Results
The reproducibility of the updated assay was evaluated with red cells of published D antigen densities. The current results matched the known ones closely. The new weak D types 164 and 165 carried 4500 and 1505 D antigens/red cell, respectively. The absolute D antigen density decreased from 27,231 to 26,037 in an individual over 19 years.
Discussion
The updated assay gave highly reproducible results for the D antigen densities of Rh phenotypes. Readily available anti‐Ds allowed for the determination of the D antigen densities of 7 weak D types. The assay is suitable to evaluate the effects of distinct amino acid substitutions on the RhD phenotype.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Immunogenetics, Red Cross Transfusion Service for Upper Austria, Linz, Austria.
ORCID profiles: Chloe Jayne Hutchison, Kshitij Srivastava, Helene Polin, Marina Ursula Bueno, Willy Albert Flegel
Funding
- Intramural NIH HHS
- NIH Clinical Center
Cite
APA
Hutchison, C. J., Srivastava, K., Polin, H., Bueno, M. U., & Flegel, W. A. (2023). Rh flow cytometry: An updated methodology for D antigen density applied to weak D types 164 and 165. Transfusion. https://doi.org/10.1111/trf.17543
Vancouver
Hutchison CJ, Srivastava K, Polin H, Bueno MU, Flegel WA. Rh flow cytometry: An updated methodology for D antigen density applied to weak D types 164 and 165. Transfusion. 2023. doi:10.1111/trf.17543
BibTeX
@article{Hutchison2023,
author = {Hutchison, Chloe Jayne and Srivastava, Kshitij and Polin, Helene and Bueno, Marina Ursula and Flegel, Willy Albert},
title = {Rh flow cytometry: An updated methodology for D antigen density applied to weak D types 164 and 165},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17543}
}
EUVIMED